Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
02/24/2023* -- Results Q4 2022 -- -1.00 --
11/03/2022 -- Results Q3 2022 -1.37 -1.06 -29.25%
08/04/2022 -- Results Q2 2022 -1.41 -1.15 -22.61%
05/05/2022 -- Results Q1 2022 -1.26 -1.02 -23.93%
02/24/2022 -- Results Q4 2021 -0.91 -0.73 -24.38%
11/04/2021 -- Results Q3 2021 -0.84 -0.67 -24.75%
08/04/2021 -- Results Q2 2021 -0.79 -0.69 -15.21%
05/06/2021 -- Results Q1 2021 -0.47 -0.44 -7.11%
*Estimated Date/Time

Earnings

Next Report Date 02/24/2023 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 11/03/2022
Beat/Miss Upgrade
Return Since 1.84%
Last FQE 09/30/2022
Next FQE 12/30/2022

Profile

Edit
SpringWorks Therapeutics Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.
URL https://www.springworkstx.com
Investor Relations URL https://ir.springworkstx.com/
HQ State/Province Connecticut
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Value
Next Earnings Release Feb. 24, 2023 (est.)
Last Earnings Release Nov. 03, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0.00%
Forward Yield --
Payout Ratio --
Cash Payout Ratio --
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
--
--
--
--
--
88.41%
-14.53%
-61.55%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-14.29%
-87.17%
63.37%
16.67%
-79.93%
-17.17%
8.91%
-45.97%
-82.70%
-9.04%
-23.93%
70.05%
-17.52%
10.42%
-13.60%
-24.30%
-67.01%
-18.25%
-29.46%
-55.16%
-57.46%
-66.95%
321.7%
-47.71%
-88.12%
56.85%
-66.70%
-33.39%
-96.85%
-9.48%
-24.44%
-28.93%
-74.38%
As of November 25, 2022.

Profile

Edit
SpringWorks Therapeutics Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.
URL https://www.springworkstx.com
Investor Relations URL https://ir.springworkstx.com/
HQ State/Province Connecticut
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Value
Next Earnings Release Feb. 24, 2023 (est.)
Last Earnings Release Nov. 03, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
ATL1637 3.699M USD 1.87%
CIB159 2.811M USD 1.51%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Nasdaq Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter SWTX Tweets